“I found myself more comfortable in challenging situations. And in the mountains, I started developing the perspective, because of the nature of the game, where you'd have to ask yourself, sometimes, is anybody's life going to be lost here if this doesn't go correctly?... The answer was, yes, it was really worth that kind of stress and seriousness. But in business, oftentimes, the answer is no. Okay, let's not get too hung up about that. Let's play the game and keep going.” - John Climaco
In today’s episode, John Climaco discusses the inner workings of developing treatments for cancers and how he took on the challenge to change people’s lives. He highlights the value of the human experience in the organization and how we should display our character with confidence as we carry on with life.
John M. Climaco, Esq. (53) is the Chairman and CEO of CNS Pharmaceuticals, Inc. (Nasdaq:CNSP), a company developing novel treatments for brain and central nervous system cancers. CNSP’s lead drug, Berubicin, is an exciting discovery for the treatment of Glioblastoma Multiforme (GBM) and potentially for other CNS malignancies. Berubicin was first discovered at the MD Anderson Cancer Center, the largest cancer research institute in the world, and is an FDA-designated Orphan Drug. In 2017 CNSP acquired all data and know-how related to the successful Phase 1 trial of Berubicin from Reata Pharmaceuticals (Nasdaq:RETA), and in 2019 Mr. Climaco led the Company’s Nasdaq IPO. CNSP expects to commence its Phase 2 clinical trial of Berubicin for the treatment of GBM 2020. Mr. Climaco also currently serves on the board of directors of Moleculin Biotech, Inc. (Nasdaq:MBRX), a preclinical and clinical-stage pharmaceutical company focused on the development of anti-cancer drug candidates.
[00:01 - 05:35] Opening Segment
[05:36 - 14:43] The Path to Clear Focus and Vision
[14:44 - 25:39] The Position to Play and Move Forward
[25:40 - 27:18] Closing Segment
Key Quote:
“You found yourself in a combat position or a dangerous position. Ultimately, you put yourself there voluntarily, that says a lot about a person. And it says a lot about who you are, I think as a human being, what your values are and what you're able to withstand, and the adversity you're able to push through… The ability to stay focused on the mission, despite the ultimate adversity.” - John Climaco
Connect with John
Check out CNS Pharmaceuticals, Inc. (Nasdaq:CNSP), a company developing novel treatments for brain and central nervous system cancers.
Did you love the value that we are putting out in the show? LEAVE A REVIEW and tell us what you think about the episode so we can continue on putting out great content just for you! Share this episode and help someone who...
